Skip to main content

A successful strategy for the use of synergistic intravenous streptomycin in a hemodialysis patient with refractory Enterococcus faecalis bacteremia

Abstract

Streptomycin has been available for over 60 years, yet optimal dosing in hemodialysis (HD) patients is not well defined. We report the successful treatment of enterococcal bacteremia in an HD patient with intravenous (IV) penicillin G and IV streptomycin at a dose of 7.5 mg/kg after HD sessions.

This is a preview of subscription content, access via your institution.

References

  1. Akaho E, Maekawa T, Uchinashi M, Kanamori R. A study of streptomycin blood level information of patients undergoing hemodialysis. Biopharm Drug Dispos. 2002;23:47–52.

    PubMed  Article  CAS  Google Scholar 

  2. Kim-Sing A, Kays M, James V, Weart C. Intravenous streptomycin use in a patient infected with high-level, gentamicin-resistant Streptococcus faecalis. Ann Pharmacother. 1993;27:712–4.

    PubMed  CAS  Google Scholar 

  3. Morris J, Cooper R. Intravenous streptomycin: a useful route of administration. Clin Infect Dis. 1994;19:1150–1.

    PubMed  Article  CAS  Google Scholar 

  4. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications. Circulation. 2005;111:e394–433.

    PubMed  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heather Young.

About this article

Cite this article

Young, H., Swartwood, C.J., Jenkins, T.C. et al. A successful strategy for the use of synergistic intravenous streptomycin in a hemodialysis patient with refractory Enterococcus faecalis bacteremia. J Infect Chemother 17, 698–699 (2011). https://doi.org/10.1007/s10156-011-0226-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-011-0226-1

Keywords

  • Intravenous streptomycin
  • Enterococcus
  • Bacteremia
  • Hemodialysis